1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

23 Feb 2022
Admin
News Article

Dante Labs In Partnership With The Renato Dulbecco Foundation To Advance Personalized Drugs For Cancer

Dante Labs, A Global Leader In Genomics And Precision Medicine, Announced Today That It Has Partnered With The Renato Dulbecco Foundation To Provide More Personalized Therapies For Rare Diseases, Oncology And Covid-19. Protelica, The Innovative Us Biotech Company, Has Licensed Its Library Of Billions Of Pronectin Nanoantibodies And A Portfolio Of 12 Patents To The Renato Dulbecco Foundation. As Part Of The Pharmaceutical Research Collaboration, The Renato Dulbecco Foundation Will Leverage The Dante Platform To Identify Nanoantibodies And Their Efficacy For A Wide Range Of Applications, Including For The Experimental Treatment Of Covid-19 And All Of Its Variants Resistant To Traditional Therapies. And Orphan Diseases. Further R&D Activities Will Be Outsourced To Twist Biosciences."Personalized Medicine Needs Personalized Data, And It Is Through Partnerships Like Ours With The Renato Dulbecco Foundation That We Can Use The Power Of Genomic Information To Treat Disease And Ultimately Deliver Better Health Outcomes For Patients," Stated Andrea Riposati, Ceo Of Dante Labs."I Firmly Believe That This Collaboration Will Lead To The Discovery Of New Pronectins That Must Be Considered A New Generation Medicine And Will Pave The Way For The Treatment Of Still Incurable Diseases", Said Prof. Giuseppe Nistic

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!